WebDec 27, 2016 · CARMIEL, Israel, Dec. 27, 2016 -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX) (the “Company”) announced today the confirmation of the recent letter of intent to purchase ... WebNov 13, 2024 · Factors that might cause material differences include, among others: risks related to the ultimate purchase by Fundação Oswaldo Cruz of alfataliglicerase pursuant to the stated purchase intentions of the Brazilian Ministry of Health of the stated amounts, if at all; risks related to the successful conclusion of our negotiations with the ...
2024 — Comissão Nacional de Incorporação de Tecnologias no …
WebApr 29, 2013 · UPLYSO is the first plant cell-based ERT for the treatment of Gaucher disease. It is also the first approved plant cell-expressed drug that is derived from … WebFiocruz’s purchases of alfataliglicerase to date have been significantly below certain agreed upon purchase milestones and, accordingly, the Company has the right to terminate the Brazil Agreement. Notwithstanding, we are, at this time, continuing to supply alfataliglicerase to Fiocruz under the Brazil Agreement , and patients continue to be ... iphone screen repair arlington va
Protalix nabs $24M order for alfataliglicerase from Brazil; shares ...
WebApr 29, 2013 · UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease April 29, 2013 07:30 ET Source: Protalix … WebApr 29, 2013 · CARMIEL, Israel, April 29, 2013 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE-MKT:PLX) (TASE:PLX), announced today that the Mexican Federal Commission for the Protection against Sanitary Risk (COFEPRIS) and the Public Health Institute of Chile have both granted regulatory approval to UPLYSO™ … WebDec 27, 2016 · CARMIEL, Israel, Dec. 27, 2016 -- Protalix BioTherapeutics, Inc. announced today the confirmation of the recent letter of intent to purchase alfataliglicerase to treat … iphone screen repair asbury park nj